NCT00019968View on ClinicalTrials.gov

Isolated Limb Perfusion of Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Soft Tissue Sarcoma of the Arm or Leg

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

August 31, 1999

Study Completion Date

March 31, 2002

Conditions

Stage IVB Adult Soft Tissue SarcomaStage IIB Adult Soft Tissue SarcomaStage IIC Adult Soft Tissue SarcomaRecurrent Adult Soft Tissue SarcomaStage IVA Adult Soft Tissue SarcomaStage III Adult Soft Tissue Sarcoma

Interventions

DRUG

melphalan

DRUG

tumor necrosis factor

All Listed Sponsors

lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00019968 - Isolated Limb Perfusion of Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Soft Tissue Sarcoma of the Arm or Leg | Biotech Hunter | Biotech Hunter